Source: American Association of Pharmaceutical Scientists/AAPS. Unidade: FCF
Subjects: VITAMINA D, PELE
ABNT
COSTA, Gabriela Maria Dangelo et al. Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation. American Association of Pharmaceutical Scientists/AAPS, v. 19, p. 2418-2425, 2018Tradução . . Disponível em: https://doi.org/10.1208/s12249-018-1065-5. Acesso em: 11 ago. 2024.APA
Costa, G. M. D., Pinto, C. A. S. de O., Silva, V. R. L. e, Baby, A. R., & Velasco, M. V. R. (2018). Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation. American Association of Pharmaceutical Scientists/AAPS, 19, 2418-2425. doi:10.1208/s12249-018-1065-5NLM
Costa GMD, Pinto CAS de O, Silva VRL e, Baby AR, Velasco MVR. Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation [Internet]. American Association of Pharmaceutical Scientists/AAPS. 2018 ; 19 2418-2425.[citado 2024 ago. 11 ] Available from: https://doi.org/10.1208/s12249-018-1065-5Vancouver
Costa GMD, Pinto CAS de O, Silva VRL e, Baby AR, Velasco MVR. Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation [Internet]. American Association of Pharmaceutical Scientists/AAPS. 2018 ; 19 2418-2425.[citado 2024 ago. 11 ] Available from: https://doi.org/10.1208/s12249-018-1065-5